Saturday, June 20, 2026

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant

GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant

Story Highlights GlaxoSmithKline and Sanofi Pasteur are partnering to develop an experimental COVID-19 vaccine. The two global vaccine manufacturers are using existing recombinant DNA vaccine technology and a squalene adjuvant for their COVID-19 vaccine. Clinical trials are scheduled to begin in the second half of 2020 and, if successful, the vaccine will be available in […]

Pfizer/BioNTech Target Fall 2020 for COVID-19 Vaccine Availability

Pfizer/BioNTech Target Fall 2020 for COVID-19 Vaccine Availability

In recent weeks Inovio Pharmaceuticals of Pennsylvania and representatives of the German biotechnology firm CureVac AG and the University of Oxford in the United Kingdom have announced that their experimental COVID-19 vaccines will be ready for use by September 2020. On Apr. 29, 2020, Pfizer, Inc. of New York stated in a news release that […]

COVID-19 Hospitalized Patients and Underlying Chronic Disease

COVID-19 Hospitalized Patients and Underlying Chronic Disease

Story Highlights Recent research shows that most hospitalized COVID-19 patients had one or more chronic poor health conditions, such as obesity, hypertension and heart and lung disease. Chronic diseases are the leading cause of death and disability in the United States, making the U.S. population susceptible to more severe COVID-19 infections. Good nutrition helps reduce […]

Inovio COVID-19 Vaccine Uses Electricity to Drive DNA Into Body Cells

Inovio COVID-19 Vaccine Uses Electricity to Drive DNA Into Body Cells

Story Highlights Inovio Pharmaceuticals has started Phase 1 testing of its experimental COVID-19 DNA vaccine in healthy volunteers. The U.S. biotech firm has already produced enough of the vaccine to support Phase 1 (immune system reactivity and safety) and Phase 2 (efficacy) testing and plans to have one million doses ready for distribution by the […]

COVID-19 Meltdown and Pharma’s Big Money Win

COVID-19 Meltdown and Pharma’s Big Money Win

Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases (NIAID) told Americans on Apr. 1, 2020 that modeling reports suggested COVID-19 infections could eventually “kill 100,000 to 240,000 Americans,”1 2 3 which was considerably less than the worst case 1.7 million mortality figure the Centers for Disease Control and Prevention (CDC) […]

Search in Site

To search in site, type your keyword and hit enter

Search